1.Grabar, S, et al. HIV infection in older patients in the HAART era. Journal of Antimicrobial Chemotherapy 2006; 57: 4–7.
2.Kalayjian, RC, et al. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: Association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. Journal of Infectious Diseases 2003; 187: 1924–1933.
3.Appay, V, Rowland-Jones, SL. Premature ageing of the immune system: the cause of AIDS? Trends in Immunology 2002; 23: 580–585.
4.Effros, RB, et al. Aging and infectious diseases: Workshop on HIV infection and aging: What is known and future research directions. Clinical Infectious Diseases 2008; 47: 542–553.
5.Simone, MJ, Appelbaum, J. HIV in older adults. Geriatrics 2008; 63: 6–12.
6.Frame, PT. HIV disease in primary care. Primary Care 2003; 30: 205–237.
7.Valcour, VG, et al. Diabetes, insulin resistance, and dementia among HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes 2005; 38: 31–36.
8.Thompson, PM, et al. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proceedings of the National Academy of Sciences USA 2005; 102: 15647–15652.
9.Lawrence, DM, Major, EO. HIV-1 and the brain: Connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes and Infection 2002; 4: 301–308.
11.Neuzil, KM, et al. Influenza-associated morbidity and mortality in young and middle-aged women. Journal of the American Medical Association 1999; 281: 901–907.
12.Lin, JC, Nichol, KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Archives of Internal Medicine 2001; 161: 441–446.
13.Sureka, A, et al. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care and STDS 2004; 18: 99–107.
14.Crum, NF, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes 2006; 41: 194–200.
15.Mocroft, A, et al. Decline in the AIDS and death rates in the Eurosida study: An observational study. Lancet 2003; 362: 22–29.
16.Sogaard, OS, et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995–2007: A Danish population-based, nationwide cohort study. Clinical Infectious Diseases 2008; 47: 1345–1353.
17.Neuzil, KM, et al. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection. Journal of Acquired Immune Deficiency Syndromes 2003; 34: 304–307.
18.Walensky, RP, et al. The survival benefits of AIDS treatment in the United States. Journal of Infectious Diseases 2006; 194: 11–19.
19.Thompson, WW, et al. Influenza-associated hospitalizations in the United States. Journal of the American Medical Association 2004; 292: 1333–1340.
20.Cohen, SA, et al. Childhood Hib vaccination and pneumonia and influenza burden in US seniors. Vaccine 2010: 28: 4462–4469.
22.Thompson, WW, et al. Epidemiology of seasonal influenza: Use of surveillance data and statistical models to estimate the burden of disease. Journal of Infectious Diseases 2006; 194: S82–91.
23.Wenger, JB, Naumova, EN. Seasonal synchronization of influenza in the United States older adult population. PLoS One 2010; 5: e10187.
24.Alemayehu, B, Warner, KE. The lifetime distribution of health care costs. Health Services Research 2004; 39: 627–642.
25.Hebert, PL, et al. Explaining trends in hospitalizations for pneumonia and influenza in the elderly. Medical Care Research and Review 2005; 62: 560–582.
26.Thompson, WW, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 2003; 289: 179–186.
27.CDC. HIV/AIDS Surveillance Report, 2001 Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention. 2001; 13: 7.
28.CDC. HIV/AIDS Surveillance Report, 2007 Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, 2009; 19: 21.
31.Hirschtick, RE, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary complications of HIV infection study group. New England Journal of Medicine 1995; 333: 845–851.
32.Kohli, R, et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV Epidemiologic Research (HER) study. Clinical Infectious Diseases 2006; 43: 90–98.
33.Karon, JM, et al. HIV in the United States at the turn of the century: An epidemic in transition. American Journal of Public Health 2001; 91: 1060–1068.
34.Hariri, S, McKenna, MT. Epidemiology of human immunodeficiency virus in the United States. Clinical Microbiology Reviews 2007; 20: 478–488.
35.Kunisaki, KM, Janoff, EN. Influenza in immunosuppressed populations: A review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infectious Diseases 2009; 9: 493–504.
36.Anema, A, et al. Efficacy of influenza vaccination in HIV-positive patients: A systematic review and meta-analysis. HIV Medicine 2008; 9: 57–61.
37.Geretti, AM, Doyle, T. Immunization for HIV-positive individuals. Current Opinion in Infectious Diseases 2010; 23: 32–38.
38.Cohen, SA, Naumova, EN. Population dynamics in the elderly: The need for age-adjustment in national biosurveillance systems. Lecture Notes in Computer Science 2007; 47–58.
39.Tumbarello, M, et al. HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1999; 20: 208–209.
40.Krentz, HB, et al. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Medicine 2005; 6: 99–106.
41.Wolff, AJ, O'Donnell, AE. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 2001; 120: 1888–1893.